Streetbeat News

Regulatory

CVLT

Commvault's SaaS data protection offerings have achieved FedRAMP High Authorization, allowing them to securely handle sensitive government data.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:35 pm

CMPS

CYBN

MNMD

Shares of psychedelics companies are trading lower after an FDA panel rejected the approval of MDMA therapy for PTSD.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:26 pm

NNOX

Nanox Imaging Ltd. has launched AI functionality in its Second Opinions online medical consultation service, integrating FDA-cleared AI solutions to enhance early detection of chronic conditions through chest and abdominal CT scans.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:24 pm

BYDDF

BYDDY

TSLA

Chinese EV maker BYD Co opened its first dealership in the Caribbean, raising concerns among U.S. automakers about potential market entry. BYD, which has surpassed Tesla in overall vehicle sales, has no current plans to enter the U.S. market but is exploring plant sites in Mexico. President Biden has imposed tariffs on Chinese EV imports to protect American manufacturers.

Portfolio Pulse from Anan Ashraf

June 05, 2024 | 12:16 pm

BNTX

PFE

Pfizer and BioNTech have announced their readiness to supply either the JN.1 or KP.2 Covid vaccines immediately upon approval.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:15 pm

MRNA

Moderna announced its readiness to submit for approval a COVID-19 vaccine targeting either the JN.1 or KP.2 variant.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:14 pm

ADIL

Adial Pharmaceuticals (NASDAQ:ADIL) has begun dosing patients in a pharmacokinetics study of AD04 for Alcohol Use Disorder. The study aims to optimize the design for a Phase 3 clinical trial and meet FDA requirements. Results are expected in early Q4 2024.

Portfolio Pulse from Vandana Singh

June 05, 2024 | 12:00 pm

NVDA

SOXQ

TSM

USD

Taiwan Semiconductor Manufacturing Co (TSMC) is seeing a rise in stock price as it navigates U.S. sanctions affecting Chinese AI chip firms. The sanctions have led to a redesign of less powerful processors by Chinese firms and have impacted companies like Nvidia. TSMC is also looking to increase service prices amid the AI boom. The stock has gained 56% in the last 12 months.

Portfolio Pulse from Anusuya Lahiri

June 05, 2024 | 11:44 am

CANF

Can-Fite Biopharma announced that its Phase 3 study for Namodenoson, a treatment for advanced liver cancer, is now recruiting at 31 medical centers. Namodenoson has received Orphan Drug status from both the FDA and the European Medicines Agency, as well as FDA Fast Track status. Additionally, a compassionate use program is ongoing in Israel and Romania.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:18 am

ESTA

The FDA's Center for Devices and Radiological Health has completed its review of Establishment Labs' premarket approval application for Motiva Implants. The application is deemed approvable pending an acceptable FDA inspection of the manufacturing facilities, which has been rescheduled to occur within the next thirty days.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:13 am